Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
It was reported that after vns surgery the device was turned on, stimulation started and the patient had bradycardia (47 bpm to 25).The surgeon, then removed the leads from the generator and let the patient's heart rate return to normal.The leads were then reconnected, the generator returned to 0 ma, and a low setting was programmed and a slight hr decrease was seen but not as drastic as initially seen with the fully programmed settings, and then on the next stimulation, the hr didn't decrease at all.The bradycardia wasn't seen during system diagnostics but during normal cyclic stimulation after programming on.The surgeon was going to wait a while and then decide whether to titrate back up to the settings originally programmed.Later it was discovered that the patient has a history of a low heart rate.The patient is on their initially programmed settings and tolerated it.It was not determined of this history of low heart rate was the cause of the event during surgery , or if vns exacerbated this.No other relevant information has been received to date.
|